Image Guided Radiation Therapy For Prostate Cancer

StatusCompleted
PhasePhase 3
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study Status, Study Design, Referencesv4
  2. Trial status: Recruiting to Completedv3 Show 6 more changesShow less
    • Enrollment target: estimated 520 to confirmed 470
    • Primary completion date: Oct 2012
    • Study completion date: Sep 2007 to Nov 2012
    • Interventions: Control position by 3DOBI before the fraction (Procedure) to Control position by 3DOBI before the fraction (Procedure), Standard imaging (Procedure)
    • Site details revised
    • Study arms: 0 to 2
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Mar 2007 to Jun 2007
    • Study completion date: Sep 2007
    • Site details revised
    v2
  4. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
During the 7 to 8 weeks of conformal radiotherapy for prostate carcinoma, the prostate has an intra-pelvic motion which is not detectable by the conventional portal imaging. This prostate motion may lead to a mistargeting, which possibly decreases the local control. On the other hand, the new 3D on board imaging (3D OBI) allows to localize the target but is expensive. The cost/effectiveness ratio is not well established, as well as the frequency of using such imaging during the course of radiation.
Trial Details
NCT Number NCT00433706
Lead Sponsor Gustave Roussy, Cancer Campus, Grand Paris
Collaborators: National Cancer Institute, France
Conditions
(from sponsor)		 Prostate Cancer
Related terms Prostatic Neoplasms
Enrollment 470 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov